OSCR
Oscar Health, Inc.
OSCR's fundamentals are strong: revenue grew 55% and its operating margin went from −1.9% to 5.4%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
RDHL
RedHill Biopharma Ltd.
There isn't enough reported data to score RDHL yet.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
RDHL Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Unavailable |
RDHL's profitability is currently healthy. There isn't enough data to rate its revenue, cash flow and balance sheet.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
RDHL PE Valuation
RDHL has no meaningful PE right now: it lost money over the past year.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
RDHL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| -- | |
| Limited | |
| High |
Analysts expect RDHL's losses to shrink, with revenue growing.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over RDHL in the latest year-over-year earnings comparison.
RDHL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2023 | $0.25 | +$120.25 |
| Q2 2023 | -$59.00 | +$99.35 |
| Q4 2022 | -$120.00 | +$98.35 |
| Q2 2020 | -$300.00 | -$153.15 |
| Q4 2019 | -$280.00 | -$103.15 |
| Q4 2018 | -$176.85 | +$83.15 |
| Q4 2017 | -$260.00 | +$890.00 |
RDHL has returned to profit: it earned $0.25 per share over the past year, after losing money the year before.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over RDHL in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR's operating margin was 3.5% last quarter, up 7.8 points from the same quarter a year ago.
RDHL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $4.1M | +59% |
| Q4 2024 | $5.5M | +382% |
| Q2 2024 | $2.6M | -52% |
| Q4 2023 | $1.1M | -96% |
| Q2 2023 | $5.4M | -83% |
| Q4 2022 | $30.4M | -31% |
| Q2 2022 | $31.5M | -25% |
| Q4 2021 | $43.7M | +3% |
RDHL's revenue has slid since its 2021 peak: $4M last quarter, down 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -107% | -565 points |
| Q4 2024 | -113% | -57 points |
| Q2 2024 | -328% | -247 points |
| Q4 2023 | -1061% | -974 points |
| Q2 2023 | 457% | +560 points |
| Q4 2022 | -56% | +24 points |
| Q2 2022 | -82% | +52 points |
| Q4 2021 | -87% | +635 points |
RDHL's operating margin was −107% last quarter, down 565 points from the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $4.1B over the past year.
RDHL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | -$5M | +$1.2M |
| Q4 2024 | -$3.2M | +$14.9M |
| Q2 2024 | -$6.2M | +$11.6M |
| Q4 2023 | -$18M | -$9.6M |
| Q2 2023 | -$17.8M | +$3.1M |
| Q4 2022 | -$8.5M | +$25.4M |
| Q2 2022 | -$20.9M | +$10.3M |
| Q4 2021 | -$33.9M | -$11.8M |
RDHL has burned cash in almost every quarter: −$32M over the past year, against −$81M the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has the edge over RDHL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
RDHL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9252% | +50.6M shares |
| 1 year | +13933% | +50.8M shares |
| 3 years | +200407% | +51.1M shares |
RDHL has 51M diluted shares, up 13933% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2016 | — |
| Q3 2016 | — |
| Q2 2016 | — |
| Q1 2016 | — |
| Q4 2015 | — |
| Q3 2015 | — |
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
RDHL Net Leverage
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
RDHL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.9 | Neutral |
| Stochastic | 2.1 | Oversold |
RDHL's weekly RSI is 31 (neutral) and its Stochastic is 2 (oversold).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
RDHL PE vs Healthcare Sector
RDHL has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over RDHL on trend strength, trading above more of its moving averages.
RDHL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.45 | 16% below |
| 20 week MA | $0.58 | 34% below |
| 50 week MA | $0.84 | 55% below |
| 100 week MA | $1.75 | 78% below |
| 200 week MA | $20.6 | 98% below |
RDHL is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over RDHL on returns for 2026, with the stronger performance.
RDHL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6,050.0 | $9,320.0 | +54% |
| 2021 | $9,320.0 | $2,640.0 | -72% |
| 2022 | $2,640.0 | $158.5 | -94% |
| 2023 | $158.5 | $36.5 | -77% |
| 2024 | $36.5 | $6.91 | -81% |
| 2025 | $6.91 | $1.14 | -84% |
| 2026 YTD | $1.14 | $0.38 | -67% |
RDHL has finished five years in a row lower, and it's down 67% so far in 2026.